We are live on
!
Find out more
GS
Gagnon Securities Portfolio holdings
AUM
$519M
1-Year Est. Return
44.91%
This Fund
S&P 500
This Quarter
Est. Return
-6.04%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$673M
AUM Growth
-$31.2M
(-4.4%)
Cap. Flow
+$28.1M
Cap. Flow
% of AUM
4.17%
Top 10 Holdings %
Top 10 Hldgs %
41.71%
Holding
120
New
9
Increased
49
Reduced
35
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVA
Enviva Inc.
EVA
|
+$13.9M |
| 2 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
+$10.4M |
| 3 |
Freshworks
FRSH
|
+$9.41M |
| 4 |
GeneDx Holdings
WGS
|
+$6.85M |
| 5 |
ZUO
Zuora, Inc.
ZUO
|
+$6.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMLFU
CM Life Sciences, Inc. Unit
CMLFU
|
+$10.3M |
| 2 |
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
|
+$10.2M |
| 3 |
Ameresco
AMRC
|
+$7.52M |
| 4 |
Devon Energy
DVN
|
+$6.26M |
| 5 |
Onto Innovation
ONTO
|
+$5.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.68% |
| 2 | Technology | 27.2% |
| 3 | Industrials | 12.25% |
| 4 | Consumer Discretionary | 11.03% |
| 5 | Energy | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
101
DELISTED
Zogenix, Inc.
ZGNX
| $190K | 0.03% |
12,500
| – | – |
|
102
Dynagas LNG Partners
DLNG
$132M
| $166K | 0.02% |
54,112
| – | – |
|
|
RADA
103
DELISTED
Rada Electronic Industries Ltd
RADA
| $146K | 0.02% |
13,756
-14,973
| -52% | -$173K |
|
|
APTO
104
DELISTED
Aptose Biosciences, Inc.
APTO
| $129K | 0.02% |
132
-111
| -46% | -$139K |
|
|
CEMI
105
DELISTED
Chembio diagnostics, Inc.
CEMI
| $119K | 0.02% |
47,793
-232
| -0.5% | -$644 |
|
|
DMTK
106
DELISTED
DermTech, Inc. Common Stock
DMTK
| – | – |
-6,072
| Closed | -$252K |
|
|
QUMU
107
DELISTED
Qumu Corp.
QUMU
| – | – |
-35,999
| Closed | -$104K |
|
|
CMLTU
108
DELISTED
CM Life Sciences III Inc. Unit
CMLTU
| – | – |
-468,907
| Closed | -$5.13M |
|
|
CMIIU
109
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
| – | – |
-761,193
| Closed | -$10.2M |
|
|
CMLFU
110
DELISTED
CM Life Sciences, Inc. Unit
CMLFU
| – | – |
-656,269
| Closed | -$10.3M |
|
|
MNK
111
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
-218,143
| Closed | -$63K |
|
Similar funds
CI
WPP
CFM
LHC
AAM
RCI
SCM
SC
Gagnon Securities's Q3 2021 Portfolio in Review
As of Q3 2021, Gagnon Securities held 120 positions worth $673M, down 4.4% from $704M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Gagnon Securities deployed $28.1M of net new capital in Q3 2021, opening 9 new positions and adding to 49 existing holdings. Its largest new stake was Enviva Inc.: 258,297 shares worth $14M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Ameresco, an estimated $7.52M trimmed.
- Gagnon Securities's largest Q3 2021 buy was Enviva Inc.: 258,297 shares worth $14M.
- Gagnon Securities added most to GeneDx Holdings in Q3 2021, an estimated $6.85M increase.
- Gagnon Securities's biggest Q3 2021 reduction was Ameresco, cutting an estimated $7.52M.
- Gagnon Securities fully exited CM Life Sciences, Inc. Unit in Q3 2021, selling an estimated $10.3M.
- Gagnon Securities's ten largest holdings make up 42% of its $673M portfolio in Q3 2021.
- Gagnon Securities opened 9 new positions and closed 8 in Q3 2021.
- Gagnon Securities's portfolio value fell 4.4% quarter-over-quarter to $673M.
Based on Gagnon Securities's 13F filing for Q3 2021, filed 12 Nov 2021.